TY - JOUR T1 - Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation 鈥� a registry study on behalf of the EBMT Acute Leukemia Working Party JO - Bone Marrow Transplantation UR - http://dx.doi.org/10.1038/s41409-023-02150-w PY - 2023/12/02 AU - Duque-Afonso J AU - Finke J AU - Ngoya M AU - Galimard J-E AU - Craddock C AU - Raj K AU - Bloor A AU - Nicholson E AU - Eder M AU - Kim O AU - Valerius T et al ED - DO - DOI: 10.1038/s41409-023-02150-w PB - Springer Science and Business Media LLC Y2 - 2025/07/03 ER -